Differential expression of vitamin e and selenium-responsive genes by disease severity in chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 10, Issue 4, 2013, Pages 450-458

  Agler, Anne H ^a   Crystal, Ronald G ^b   Mezey, Jason G ^a,b   Fuller, Jennifer ^b   Gao, Chuan ^a   Hansen, Joyanna G ^a   Cassano, Patricia A ^a  

^a Cornell University ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Antioxidants; COPD; Gene expression; Selenium; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; CELL NUCLEUS RECEPTOR; COLAGEN TYPE 1 A1; COLLAGEN TYPE 1; CYTOKERATIN 1; CYTOKERATIN 4; GLUTATHIONE S TRANSFERASE OMEGA 1; GLUTATHIONE TRANSFERASE; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN SUBUNIT GAMMA 2; MEMBRANE SPANNING 4 DOMAINS SUBFAMILY A MEMBER 1; NUCLEAR RECEPTOR SUBFAMILY 2 GROUP F MEMBER 1; PEPTIDES AND PROTEINS; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYL 4 HYDROXYLASE ALPHA POLYPEPTIDE; SELENIUM; SELENOPROTEIN; SELENOPROTEIN T; SERINE PROTEINASE INHIBITOR; SERPINE 2; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR RNA ACTIVATOR 1; SULFOTRANSFERASE; SULFOTRANSFERASE FAMILY CYTOSOLIC 2B MEMBER 1; TROPONIN I; TROPONIN I TYPE 2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC RISK; HUMAN; HUMAN TISSUE; HYPOTHESIS; LUNG PARENCHYMA; MALE; NUTRITIONAL STATUS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ALPHA-TOCOPHEROL; ANTIOXIDANTS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LUNG; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RNA; SELENIUM; SEVERITY OF ILLNESS INDEX;

EID: 84880760566     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2012.761958     Document Type: Article

References (69)

1. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S. Chronic obstructive pulmonary disease: Current burden and future projections. Eur Respir J 2006; 27:397-412.
2. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med 1998; 4:1241-1243.
3. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, Connell C, Jemal A, Lee TA, Miravitlles M, Aldington S, Beasley R. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27:188-207.
4. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the united states, 1970-2002. JAMA 2005; 294:1255-1259.
5. Minino AM. Death in the united states, 2009. National Center for Health Statistics data brief 2011:1-8.
6. Shavelle RM, Paculdo DR, Kush SJ, Mannino DM, Strauss DJ. Life expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the nhanes iii follow-up study. Int J Chron Obstruct Pulmon Dis 2009; 4:137-148.
7. Wilson L, Devine EB, So K. Direct medical costs of chronic obstructive pulmonary disease: Chronic bronchitis and emphysema. Respir Med 2000; 94:204-213.
8. Silverman EK, Spira A, Pare PD. Genetics and genomics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009; 6:539-542.
9. Bhattacharya S, Mariani TJ. Array of hop e: Expression profiling identifies disease biomarkers and mechanism. Biochem Soc Trans 2009; 37: 855-862.
10. Bentley AR, Emrani P, Cassano PA. Genetic variation and gene expression in antioxidant related enzymes and risk of copd: A systematic review. Thorax 2008; 63:956-961.
11. Kong X, Cho MH, Anderson W, Coxson HO, Muller N, Washko G, Hoffman EA, Bakke P, Gulsvik A, Lomas DA, Silverman EK, Pillai SG. Genome-wide association study identifies bicd1 as a susceptibility gene for emphysema. Am J Respir Crit Care Med 2011; 183:43-49.
12. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, Feng S, Hersh CP, Bakke P, Gulsvik A, Ruppert A, Lodrup Carlsen KC, Roses A, Anderson W, Rennard SI, Lomas DA, Silverman EK, Goldstein DB. A genome-wide association study in chronic obstructive pulmonary disease (COPD): Identification of two major susceptibility loci. PLoS Genet 2009; 5:e1000421.
13. Pillai SG, Kong X, Edwards LD, Cho MH, Anderson WH, Coxson HO, Lomas DA, Silverman EK. Loci identified by genome-wide association studies infl uence different disease-related phenotypes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182:1498-1505.
14. Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Hersh C P, DeMeo DL, Hunninghake GM, Litonjua AA, Sparrow D, Lange C, Won S, Murphy JR, Beaty TH, Regan EA, Make BJ, Hokanson JE, Crapo JD, Kong X, Anderson WH, Tal-Singer R, Lomas DA, Bakke P, Gulsvik A, Pillai SG, Silverman EK. Variants in fam13a are associated with chronic obstructive pulmonary disease. Nat Genet 2010; 42:200-202.
15. Van Durme YM, Eijgelsheim M, Joos GF, Hofman A, Uitterlinden AG, Brusselle GG, Stricker BH. Hedgehog-interacting protein is a copd susceptibility gene: The rotterdam study. Eur Respir J 2010; 36:89-95.
16. Demeo DL, Mariani TJ, Lange C, Srisuma S, Litonjua AA, Celedon JC, Lake SL, Reilly JJ, Chapman HA, Mecham BH, Haley KJ, Sylvia JS, Sparrow D, Spira AE, Beane J, Pinto-Plata V, Speizer FE, Shapiro SD, Weiss ST, Silverman EK. The serpine2 gene is associated with chronic obstructive pulmonary disease. Am J Hum Genet 2006; 78:253-264.
17. DeMeo DL, Silverman EK. Genetics of chronic obstructive pulmonary disease. Semin Respir Crit Care Med 2003; 24:151-160.
18. Hersh C P, Pillai SG, Zhu G, Lomas DA, Bakke P, Gulsvik A, DeMeo DL, Klanderman BJ, Lazarus R, Litonjua AA, Sparrow D, Reilly JJ, Agusti A, Calverley PM, Donner CF, Levy RD, Make BJ, Pare PD, Rennard SI, Vestbo J, Wouters EF, Scholand MB, Coon H, Hoidal J, Silverman EK. Multistudy fine mapping of chromosome 2q identifies xrcc5 as a chronic obstructive pulmonary disease susceptibility gene. Am J Respir Crit Care Med 2010; 182:605-613.
19. Gosselink J V, Hayashi S, Elliott WM, Xing L, Chan B, Yang L, Wright C, Sin D, Pare PD, Pierce JA, Pierce RA, Patterson A, Cooper J, Hogg JC. Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181:1329-1335.
20. Tomaki M, Sugiura H, Koarai A, Komaki Y, Akita T, Matsumoto T, Nakanishi A, Ogawa H, Hattori T, Ichinose M. Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung. Pulm Pharmacol Ther 2007; 20:596-605.
21. Steiling K, Lenburg ME, Spira A. Airway gene expression in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009; 6:697-700.
22. Llinas L, Peinado VI, Ramon Goni J, Rabinovich R, Pizarro S, Rodriguez-Roisin R, Barbera JA, Bastos R. Similar gene expression profiles in smokers and patients with moderate copd. Pulm Pharmacol Ther 2011; 24:32-41.
23. Belvisi MG, Mitchell JA. Targeting ppar receptors in the airway for the treatment of infl ammatory lung disease. Br J Pharmacol 2009; 158:994-1003.
24. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2:50-60.
25. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative stress study group. Am J Respir Crit Care Med 1997; 156:341-357.
26. Bowler R P, Barnes PJ, Crapo JD. The role of oxidative stress in chronic obstructive pulmonary disease. COPD 2004; 1:255-277.
27. MacNee W. Oxidants/antioxidants and copd. Chest 2000; 117:303S-317S.
28. Dekhuijzen PN, Aben KK, Dekker I, Aarts L P, Wielders PL, van Herwaarden CL, Bast A. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154:813-816.
29. Lin JL, Thomas PS. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease. COPD 2010; 7:291-306.
30. Gosker HR, Bast A, Haenen GR, Fischer MA, van der Vusse GJ, Wouters EF, Schols AM. Altered antioxidant status in peripheral skeletal muscle of patients with copd. Respir Med 2005; 99:118-125.
31. Sadowska AM, Luyten C, Vints AM, Verbraecken J, Van Ranst D, De Backer WA. Systemic antioxidant defences during acute exacerbation of chronic obstructive pulmonary disease. Respirology 2006; 11:741-747.
32. Yamaoka S, Kim HS, Ogihara T, Oue S, Takitani K, Yoshida Y, Tamai H. Severe vitamin e deficiency exacerbates acute hyperoxic lung injury associated with increased oxidative stress and infl ammation. Free Radic Res 2008; 42:602-612.
33. Silva Bezerra F, Valenca SS, Lanzetti M, Pimenta WA, Castro P, Goncalves Koatz VL, Porto LC. Alpha-tocopherol and ascorbic acid supplementation reduced acute lung infl ammatory response by cigarette smoke in mouse. Nutrition 2006; 22:1192-1201.
34. McKeever TM, Lewis SA, Smit HA, Burney P, Cassano PA, Britton J. A multivariate analysis of serum nutrient levels and lung function. Respir Res 2008; 9:67.
35. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, Romieu I, Silverman EK, Balmes JR. An official american thoracic society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182:693-718.
36. Goulet AC, Watts G, Lord JL, Nelson MA. Profiling of selenomethionine responsive genes in colon cancer by microarray analysis. Cancer Biol Ther 2007; 6:494-503.
37. Hooven LA, Butler J, Ream LW, Whanger PD. Microarray analysis of selenium-depleted and selenium-supplemented mice. Biol Trace Elem Res 2006; 109:173-179.
38. Hurst R, Elliott RM, Goldson AJ, Fairweather-Tait SJ. Se-methylselenocysteine alters collagen gene and protein expression in human prostate cells. Cancer Lett 2008; 269:117-126.
39. Sunde RA, Raines AM, Barnes KM, Evenson JK. Selenium status highly regulates selenoprotein mrna levels for only a subset of the selenoproteins in the selenoproteome. Biosci Rep 2009; 29:329-338.
40. Reeves MA, Hoffmann PR. The human selenoproteome: Recent insights into functions and regulation. Cell Mol Life Sci 2009; 66:2457-2478.
41. Pagmantidis V, Meplan C, van Schothorst EM, Keijer J, Hesketh JE. Supplementation of healthy volunteers with nutritionally relevant amounts of selenium increases the expression of lymphocyte protein biosynthesis genes. Am J Clin Nutr 2008; 87:181-189.
42. Rimbach G, Moehring J, Huebbe P, Lodge JK. Gene-regulatory activity of alpha-tocopherol. Molecules 2010; 15:1746-1761.
43. Nakamura YK, Omaye, S. Vitamin e-modulated gene expression associated with ros generation. J Funct Foods 2009; I:12.
44. Han SN, Pang E, Zingg JM, Meydani SN, Meydani M, Azzi A. Differential effects of natural and synthetic vitamin e on gene transcription in murine t lymphocytes. Arch Biochem Biophys 2010; 495:49-55.
45. Azzi A, Gysin R, Kempna P, Munteanu A, Negis Y, Villacorta L, Visarius T, Zingg JM. Vitamin e mediates cell signaling and regulation of gene expression. Ann NY Acad Sci 2004; 1031:86-95.
46. Bardowell SA, Stec DE, Parker RS. Common variants of cytochrome p450 4f2 exhibit altered vitamin e-{omega}-hydroxylase specific activity. J Nutr 2010; 140:1901-1906.
47. Mustacich DJ, Gohil K, Bruno RS, Yan M, Leonard SW, Ho E, Cross CE, Traber MG. Alpha-tocopherol modulates genes involved in hepatic xenobiotic pathways in mice. J Nutr Biochem 2009; 20:469-476.
48. Mallonee DH, Crowdus CA, Barger JL, Dawson KA, Power RF. Use of stringent selection parameters for the identification of possible selenium-responsive marker genes in mouse liver and gastrocnemius. Biol Trace Elem Res 2010; 143:992-1006.
49. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National heart, lung, and blood institute and world health organization global initiative for chronic obstructive lung disease (gold): Executive summary. Respir Care 2001; 46:798-825.
50. Mannino DM. Spirometric screening: Does it work? Thorax 2006; 61:834-835.
51. Global obstructive lung dis ease cla ssifications, 2005 guidelines. 2011 [cited 2011 January 18]. Available from: http://www.goldcopd.com.
52. Expression profiling-best practices for data generation and interpretation in clinical trials. Nat Rev Genet 2004; 5:229-237.
53. Raman T, O'Connor TP, Hackett NR, Wang W, Harvey BG, Attiyeh MA, Dang DT, Teater M, Crystal RG. Quality control in microarray assessment of gene expression in human airway epithelium. BMC Genomics 2009; 10:493.
54. Halvorsen M, Martin JS, Broadaway S, Laederach A. Disease-associated mutations that alter the rna structural ensemble. PLoS Genet 2010; 6:e1001074.
55. Gao C, Tignor N, Salit J, Strulovici-Barel Y, Hackett N, Crystal G. R, Mezey J. Hidden Expression Factor analysis (HEFT): Expression Quantitative Trait Loci (eQTL) analysis of many thousands of expressed genes while simultaneously controlling for hidden factors. Submitted for publication.
56. Lin YC, Wu TC, Chen PY, Hsieh LY, Yeh SL. Comparison of plasma and intake levels of antioxidant nutrients in patients with chronic obstructive pulmonary disease and healthy people in taiwan: A case-control study. Asia Pac J Clin Nutr 2010; 19:393-401.
57. Ford ES, Schleicher RL, Mokdad AH, Ajani UA, Liu S. Distribution of serum concentrations of alpha-tocopherol and gamma-tocopherol in the us population. Am J Clin Nutr 2006; 84:375-383.
58. Redlich CA, Grauer JN, Van Bennekum AM, Clever SL, Ponn RB, Blaner WS. Characterization of carotenoid, vitamin a, and alpha-tocopheral levels in human lung tissue and pulmonary macrophages. Am J Respir Crit Care Med 1996; 154:1436-1443.
59. Tangney CC, Stibolt TB Jr, Zheutlin L, Jacobs E, Hanley M. Comparison of vitamin e levels in plasma, bronchoalveolar lavage, and lung tissues of adult pulmonary patients. J Amer Coll Nutr 1989; 8:203-214.
60. Laclaustra M, Stranges S, Navas-Acien A, Ordovas JM, Guallar E. Serum selenium and serum lipids in us adults: National health and nutrition examination survey (nhanes) 2003-2004. Atherosclerosis 2010; 210:643-648.
61. Ito K, Barnes PJ. Copd as a disease of accelerated lung aging. Chest 2009; 135:173-180.
62. Houben JM, Mercken EM, Ketelslegers HB, Bast A, Wouters EF, Hageman GJ, Schols AM. Telomere shortening in chronic obstructive pulmonary disease. Respir Med 2009; 103:230-236.
63. Suzuki M, Betsuyaku T, Nagai K, Fuke S, Nasuhara Y, Kaga K, Kondo S, Hamamura I, Hata J, Takahashi H, Nishimura M. Decreased airway expression of vascular endothelial growth factor in cigarette smoke-induced emphysema in mice and copd patients. Inhal Toxicol 2008; 20:349-359.
64. de Torres JP, Casanova C, Pinto-Plata V, Varo N, Restituto P, Cordoba-Lanus E, Baz-Davila R, Aguirre-Jaime A, Celli BR. Gender differences in plasma biomarker levels in a cohort of copd patients: A pilot study. PloS One 2011; 6:e16021.
65. Baraldo S, Bazzan E, Zanin ME, Turato G, Garbisa S, Maestrelli P, Papi A, Miniati M, Fabbri LM, Zuin R, Saetta M. Matrix metalloproteinase-2 protein in lung periphery is related to copd progression. Chest 2007; 132:1733-1740.
66. Mocchegiani E, Giacconi R, Costarelli L. Metalloproteases/anti- metalloproteases imbalance in chronic obstructive pulmonary disease: Genetic factors and treatment implications. Curr Opin Pulmon Med 2011; 17 Suppl 1:S11-19.
67. Penyige A, Poliska S, Csanky E, Scholtz B, Dezso B, Schmelczer I, Kilty I, Takacs L, Nagy L. Analyses of association between ppar gamma and ephx1 polymorphisms and susceptibility to COPD in a hungarian cohort, a case-control study. BMC Med Genet 2010; 11:152.
68. Sakamoto K, Aragaki T, Morita K, Kawachi H, Kayamori K, Nakanishi S, Omura K, Miki Y, Okada N, Katsube K, Takizawa T, Yamaguchi A. Down-regulation of keratin 4 and keratin 13 expression in oral squamous cell carcinoma and epithelial dysplasia: A clue for histopathogenesis. Histopathology 2011; 58:531-542.
69. Fahling M, Mrowka R, Steege A, Martinka P, Persson PB, Thiele BJ. Heterogeneous nuclear ribonucleoprotein-a2/b1 modulate collagen prolyl 4-hydroxylase, alpha (i) mrna stability. J Biol Chem 2006; 281:9279-9286.